Effects of cigarette smoking on hematological parameters and von Willebrand factor functional activity levels in asymptomatic male and female Arab smokers

Medical Principles and Practice

Volumn 17, Issue 2, 2008, Pages 149-153

  Al Awadhi, Anwar M ^a   Alfadhli, Suad M ^a   Mustafa, Nada Y ^a   Sharma, Prem N ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Enzyme linked immunoassay; Gender; Smoking; Von Willebrand factor

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G ANTIBODY; VON WILLEBRAND FACTOR;

ADULT; ANALYZER; ARAB; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING; CIGARETTE SMOKING; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; ARABS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KUWAIT; LEUKOCYTE COUNT; LINEAR MODELS; MALE; SEX FACTORS; SMOKING; VON WILLEBRAND FACTOR;

EID: 39749129152     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112970     Document Type: Article

References (32)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 2004;328:1519-1529.
3. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993;70:707-711.
4. Blann AD, Lip GY: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis 1998;9:297-306.
5. Pittilo RM: Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Pathol 2000;81:219-230.
6. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y: Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999;93:271-278.
7. Halfon ST, Green MS, Heiss G: Smoking status and lipid levels in adults of different ethnic origins: the Jerusalem lipid research clinic program. Int J Epidemiol 1984;13:177-183.
8. Cullen P, Schulte H, Assmann G: Smoking, lipoproteins and coronary heart disease risk. Eur Heart J 1998;19:1632-1641.
9. Tsiara S, Elisaf M, Mikhailidis DP: Influence of smoking on predictors of vascular disease. Angiology 2003;54:507-530.
10. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN: The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 1998;141:133-139.
11. Blann AD, McCollum CN: Von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994;8:10-15.
12. Blann AD: Is raised von Willebrand factor a marker of endothelial cell damage? Med Hypotheses 1993;41:419-424.
13. Lip GY, Blann A: Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255-265.
14. Blaes N, Piovella F, Samaden A, Boutherin-Falson O, Ricetti M: Nicotine alters fibronectin and factor VIII/vWF in human vascular endothelial cells. Br J Haematol 1986;64:675-687.
15. Kalra J, Chaudhary AK, Prasad K: Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 1991;72:1-7.
16. Prisco D, Fedi T, Brunelli L, Chiarugi L, Lombardi A, Gianni R, Santoro E, Cappelletti C, Pepe G, Gensini GF, Abbate R: The influence of smoking on von Willebrand factor is already manifesting in healthy adolescent females: the Floren-teen (Florence Teenager) study. Int J Clin Lab Res 1999;29:150-154.
17. Kumari M, Marmot M, Brunner E: Social determinants of von Willebrand factor: the Whitehall II Study. Arterioscler Thromb Vasc Biol 2000;20:1842-1847.
18. Gader A, Bahakim H, Awadallah S, Malaika S: Ethnic variations in the haemostatic system: comparison between Arabs, Westerners (Europeans and Americans), Asians and Africans. Blood Coagul Fibrinolysis 1995;6:537-542.
19. Rastogi R, Shrivastava SS, Mehrota TN, Singh VS, Gupta MK: Lipid profile in smokers. J Assoc Physicians India 1989;37:764-766.
20. Chand S, McCraw A, Hutton R, Tuddenham EG, Goodall AH: A two-site, monoclonal antibody-based immunoassay for von Willebrand factor: demonstration that vWF function resides in a conformational epitope. Thromb Haemost 1986;55:318-324.
21. Waters D, Lesperance J, Gladstone P, Boccuzzi ST, Cook T, Hudgin R, Krip G, Higginson L: Effects of cigarette smoking on the angiographic evaluation of coronary atherosclerosis: a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation 1996;94:614-621.
22. Smith MR, Kinmonth AL, Luben RN, Bingham S, Day NE, Wareham NJ, Welch A, Khaw KT: Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis 2003;169:331-337.
23. Kawada T: Smoking-induced leukocytosis can persist after cessation of smoking. Arch Med Res 2004;35:246-250.
24. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH: Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-1773.
25. Madjid M, Awan I, Willerson JT, Casscells SW: Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945-1956.
26. Loimaala A, Rontu R, Vuori I, Mercuri M, Lehtimaki T, Nenonem A, Bond MG: Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 2006;188:363-369.
27. Tarallo P, Henny J, Gueguen R, Siest G: Reference limits of plasma fibrinogen. Eur J Clin Chem Clin Biochem 1992;30:745-751.
28. Sinha S, Luben RN, Welch A, Bingham S, Wareham NJ, Day NE, Khaw KT: Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population. Eur J Cardiovasc Prev Rehabil 2005;12:144-150.
29. Harmening, DM: Clinical Hematology and Fundamentals of Hemostasis. Philadelphia, Davis, 2002, pp 666-667.
30. Kurata M, Sasayaman Y, Yamasaki N, Kitazawa I, Hamada Y, Horri I: Mechanism for shortening PT and APTT in dogs and rats-effects of fibrinogen on PT and APTT. J Toxicol Sci 2003;28:439-443.
31. Murdock PJ, Woodhams BJ, Mathews KB, Pasi KJ: Von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to restocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost 1997;78:1272-1277.
32. Sukhu K, Poovalingam V, Mahomed R, Giangrande PL: Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol 2003;25:247-249.